Investor Relations
Strategy

Strategy

Our objective is to maintain our position as a market leader in the application of gene editing and gene modulation technologies for applications that advance human health by maintaining a sustainable, profitable business driven by customer demand for our innovative tools and services.

Focused on our market

Unique commercial operations team in the cell biology market. Able to utilize field sales, distribution and digital channels to increase market penetration.

Investing in our future

Building global, repeatable processes that scale for organic and acquired growth. Increasing productivity through capacity and throughput.

Advancing scientific leadership

Capitalising on early scientific innovations and translating to market leadership positions.

Based around people

As a knowledge-based business we invest in our people – our biggest asset.